...
首页> 外文期刊>The Journal of molecular diagnostics: JMD >Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.
【24h】

Demonstration of array-based analysis for highly multiplexed PCR assays application to detection of IGH@-BCL2 translocations in FFPE follicular lymphoma specimens.

机译:基于阵列的分析在高度多重PCR分析中的应用,可用于检测FFPE滤泡性淋巴瘤标本中的IGH @ -BCL2易位。

获取原文
获取原文并翻译 | 示例
           

摘要

We demonstrate an approach that allowed rapid development of a robust assay for the detection of chromosomal translocations. The method includes highly multiplexed PCR with analysis of the PCR products performed by array detection. As proof of principle, we applied this approach to the detection of IGH@-BCL2 translocations in DNA prepared from FFPE specimens. This translocation and specimen type were chosen because of the known difficulties associated with PCR-based detection of this lesion and the additional loss of sensitivity associated with FFPE samples. The multiplex PCR with array detection method detected the IGH@-BCL2 translocation in 26 of 36 FFPE follicular lymphoma specimens, whereas the BIOMED-2 assay detected 13 of 36 specimens. This increased sensitivity was the result of both the increased density of BCL2 primers and identification of PCR products by low-density array. The method was specific and allowed mapping of the BCL2 break point in all cases. The method detected the IGH@-BCL2 lesion when the tumor DNA was diluted more than 1:20 in normal DNA but not when it was diluted more than 1:100. This sensitivity allows detection of diagnostically relevant levels of IGH@-BCL2 but will not detect the rare cells with IGH@-BCL2 translocations in healthy individuals.
机译:我们演示了一种方法,该方法可以快速开发出用于检测染色体易位的强大分析方法。该方法包括高度多重的PCR,以及通过阵列检测对PCR产物进行分析。作为原理证明,我们将这种方法应用于从FFPE标本制备的DNA中IGH @ -BCL2易位的检测。选择这种易位和标本类型是因为已知与基于病变的基于PCR的检测相关的困难以及与FFPE样品相关的灵敏度的额外损失。阵列检测的多重PCR检测了36个FFPE滤泡性淋巴瘤标本中的26个的IGH @ -BCL2易位,而BIOMED-2分析检测了36个标本中的13个。这种增加的敏感性是BCL2引物密度增加和通过低密度阵列鉴定PCR产物的结果。该方法是特定的,并且在所有情况下都允许映射BCL2断点。当在正常DNA中将肿瘤DNA稀释度超过1:20时,该方法检测到IGH @ -BCL2病变,而当在1:100中稀释时则未检测到。这种敏感性允许检测诊断相关水平的IGH @ -BCL2,但不能检测健康个体中具有IGH @ -BCL2易位的稀有细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号